Psychotic Disorders

"Psychotic Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Descriptor ID	D011618
MeSH Number(s)	F03.700.675
Concept/Terms	Psychotic Disorders Psychotic Disorders Disorder, Psychotic Disorders, Psychotic Psychotic Disorder Psychosis Psychoses Schizoaffective Disorder Schizoaffective Disorder Disorder, Schizoaffective Disorders, Schizoaffective Schizoaffective Disorders Schizophreniform Disorders Schizophreniform Disorders Disorder, Schizophreniform Disorders, Schizophreniform Schizophreniform Disorder Psychosis, Brief Reactive Psychosis, Brief Reactive Brief Reactive Psychoses Brief Reactive Psychosis Psychoses, Brief Reactive Reactive Psychoses, Brief Reactive Psychosis, Brief

Below are MeSH descriptors whose meaning is more general than "Psychotic Disorders".

Psychiatry and Psychology [F]
Mental Disorders [F03]
Schizophrenia Spectrum and Other Psychotic Disorders [F03.700]
Psychotic Disorders [F03.700.675]

Below are MeSH descriptors whose meaning is related to "Psychotic Disorders".

Below are MeSH descriptors whose meaning is more specific than "Psychotic Disorders".

Psychotic Disorders
Psychoses, Substance-Induced

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Psychotic Disorders" by people in this website by year, and whether "Psychotic Disorders" was a major or minor topic of these publications.

Bar chart showing 27 publications over 14 distinct years, with a maximum of 5 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2004	1	0	1
2005	1	0	1
2006	1	0	1
2007	1	1	2
2008	1	0	1
2010	1	0	1
2011	3	0	3
2012	2	0	2
2013	2	0	2
2014	4	1	5
2015	1	1	2
2016	2	0	2
2017	3	0	3

Below are the most recent publications written about "Psychotic Disorders" by people in Profiles.

Foster A, Buckley P, Lauriello J, Looney S, Schooler N. Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial. J Clin Psychopharmacol. 2017 Oct; 37(5):595-599.

View in: PubMed
Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? Schizophr Res. 2018 03; 193:263-268.

View in: PubMed
Kolanowski A, Boltz M, Galik E, Gitlin LN, Kales HC, Resnick B, Van Haitsma KS, Knehans A, Sutterlin JE, Sefcik JS, Liu W, Petrovsky DV, Massimo L, Gilmore-Bykovskyi A, MacAndrew M, Brewster G, Nalls V, Jao YL, Duffort N, Scerpella D. Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence. Nurs Outlook. 2017 Sep - Oct; 65(5):515-529.

View in: PubMed
Buckley PF, Schooler NR, Goff DC, Kopelowicz A, Lauriello J, Manschreck TC, Mendelowitz A, Miller DD, Wilson DR, Ames D, Bustillo JR, Kane JM, Looney SW. Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study. Psychiatr Serv. 2016 12 01; 67(12):1370-1372.

View in: PubMed
Aggarwal A, Gopalakrishna G, Lauriello J. Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents. Clin Schizophr Relat Psychoses. 2016; 10(1):58-63.

View in: PubMed
Lauriello J, Ithman M, Gopalakrishna G. Does indication drive use, or does use drive indication? J Clin Psychiatry. 2015 Mar; 76(3):e366-7.

View in: PubMed
Lauriello J. 21st century training in psychosis. Acad Psychiatry. 2015 Apr; 39(2):151-3.

View in: PubMed
Anbalagan E, Ithman M, Lauriello J. Rechallenging clozapine after neuroleptic malignant syndrome. Psychiatr Q. 2014 Sep; 85(3):345-8.

View in: PubMed
Rahman T, Clevenger CV, Kaklamani V, Lauriello J, Campbell A, Malwitz K, Kirkland RS. Antipsychotic treatment in breast cancer patients. Am J Psychiatry. 2014 Jun; 171(6):616-21.

View in: PubMed
Buckley PF, Schooler NR, Goff DC, Hsiao J, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz AJ, Miller del D, Severe JB, Wilson DR, Ames D, Bustillo J, Mintz J, Kane JM. Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study. Schizophr Bull. 2015 Mar; 41(2):449-59.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement